Uppugunduri, C. R. S., Storelli, F., Mlakar, V., Huezo-Diaz Curtis, P., Rezgui, A., Théorêt, Y., . . . Ansari, M. (2017). The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation. Front Pharmacol.
Chicago-стиль цитированияUppugunduri, Chakradhara Rao S., et al. "The Association of Combined GSTM1 and CYP2C9 Genotype Status With the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation." Front Pharmacol 2017.
MLA-цитированиеUppugunduri, Chakradhara Rao S., et al. "The Association of Combined GSTM1 and CYP2C9 Genotype Status With the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation." Front Pharmacol 2017.